Expression of two human skeletal calcitonin receptor isoforms cloned from a giant cell tumor of bone. The first intracellular domain modulates ligand binding and signal transduction.
Open accessThe DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
Two distinct calcitonin (CT) receptor (CTR)-encoding cDNAs (designated GC-2 and GC-10) were cloned and characterized from giant cell tumor of bone (GCT). Both GC-2 and GC-10 differ structurally from the human ovarian cell CTR (o-hCTR) that we cloned previously, but differ from each other only by the presence (GC-10) or absence (GC-2) of a predicted 16-amino acid insert in the putative first intracellular domain. Expression of all three CTR isoforms in COS cells demonstrated that GC-2 has a lower binding affinity for salmon (s) CT (Kd approximately 15 nM) than GC-10 or o-hCTR (Kd approximately 1.5 nM). Maximal stimulatory concentrations of CT resulted in a mean accumulation of cAMP in GC-2 transfected cells that was greater than eight times higher than in cells transfected with GC-10 after normalizing for the number of receptor-expressing cells. The marked difference in maximal cAMP response was also apparent after normalizing for receptor number. GC-2 also demonstrated a more potent ligand-mediated cAMP response compared with GC-10 for both human (h) and sCT (the EC50 values for GC-2 were approximately 0.2 nM for sCT and approximately 2 nM for hCT; EC50 values for GC-10 were approximately 6 nM for sCT and approximately 25 nM for hCT). Reverse transcriptase PCR of GCT RNA indicated that GC-2 transcripts are more abundant than those encoding for GC-10. In situ hybridization on GCT tissue sections demonstrated CTR mRNA expression in osteoclast-like cells. We localized the human CTR gene to chromosome 7 in band q22. The distinct functional characteristics of GC-2 and GC-10, which differ in structure only in the first intracellular domain, indicate that the first intracellular domain of the CTR plays a previously unidentified role in modulating ligand binding and signal transduction via the G protein/adenylate cyclase system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The first CTR cDNA was cloned from porcine (134), followed by the cloning of the receptors from human and rat (7,81,127,187).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [81]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
A comprehensive set of sequence analysis programs for the VAX
Devereux, J., Haeberli, P., & Smithies, O. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.1part1.387 · Cited by 14,222
Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs
Kozak, M. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.2.857 · Cited by 3,293
A G Protein-Linked Receptor for Parathyroid Hormone and Parathyroid Hormone-Related Peptide
Jüppner, H., Abou-Samra, A.-B., Freeman, M., Kong, X. F., Schipani, E., Richards, J., Kolakowski, L. F., Hock, J., Potts, J. T., Kronenberg, H. M., et al. (1991) · Science · doi:10.1126/science.1658941 · Cited by 1,249
Kozak, M. (1981) · Nucleic Acids Research · doi:10.1093/nar/9.20.5233 · Cited by 1,242
Differential signal transduction by five splice variants of the PACAP receptor
Spongier, D., Waeber, C., Pantaloni, C., Holsboer, F., Bockaert, J., Seeburgt, P. H., & Journot, L. (1993) · Nature · doi:10.1038/365170a0 · Cited by 1,182
Abou-Samra, A. B., Jüppner, H., Force, T., Freeman, M. W., Kong, X. F., Schipani, E., Urena, P., Richards, J., Bonventre, J. V., & Potts, J. T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.2732 · Cited by 1,005
TopPred II: an improved software for membrane protein structure predictions
Claros, M. G., & Heijne, G. V. (1994) · Bioinformatics · doi:10.1093/bioinformatics/10.6.685 · Cited by 936
Expression cloning of a human corticotropin-releasing-factor receptor.
Chen, R., Lewis, K. A., Perrin, M. H., & Vale, W. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.8967 · Cited by 927
Seed, B., & Aruffo, A. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.10.3365 · Cited by 909
Cited by
Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy
Reubi, J. C. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0007 · Cited by 1,131
“Very limited receptor information exists for primary human tumors, but giant-cell tumors of the bone (326) and medullary carcinomas of the thyroid (327) have been reported to express calcitonin receptors.”
BackgroundPoyner, D. R., Sexton, P. M., Marshall, I., Smith, D. M., Quirion, R., Born, W., Muff, R., Fischer, J. A., & Foord, S. M. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.233 · Cited by 804
“If translation from the upstream site occurs, the receptor “signal peptide” may still be cleaved at the original site, and so receptor function would be maintained (Gorn et al., 1995).”
BackgroundCell biology of the osteoclast
Roodman, G. D. (1999) · Experimental Hematology · doi:10.1016/s0301-472x(99)00061-2 · Cited by 571
“Calcitonin acts on osteoclasts by stimulating adenylcyclase activity and cAMP accumulation, which results in immobilization of the osteoclast and contraction of the osteoclast away from the bone surface [89].”
BackgroundChristopoulos, G., Perry, K. J., Morfis, M., Tilakaratne, N., Gao, Y., Fraser, N. J., Main, M. J., Foord, S. M., & Sexton, P. M. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.1.235 · Cited by 486
“Cells cotransfected with receptor and vector control showed responses typical of a CT receptor (Kuestner et al., 1994; Albrandt et al., 1995; Gorn et al., 1995), with salmon and human CT displaying similar efficacy and amylin and CGRP only weakly stimulating cAMP accumulation.”
BackgroundHillhouse, E. W., & Grammatopoulos, D. K. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0034 · Cited by 353
“the fully active receptor variant (88).”
Calcitonin and calcitonin receptors: bone and beyond
Pondel, M. (2000) · International Journal of Experimental Pathology · doi:10.1046/j.1365-2613.2000.00176.x · Cited by 192
“Gorn et al. (1995) reported the cloning of an hCTR cDNA containing a 16 amino-acid insert in the first intracellular loop similar to the porcine C1b insert.”
MethodGastric Acid, Calcium Absorption, and Their Impact on Bone Health
Kopic, S., & Geibel, J. P. (2013) · Physiological Reviews · doi:10.1152/physrev.00015.2012 · Cited by 176
“Multiple isoforms of the calcitonin receptor occur in the body, which results from different RNA splicing directed by tissue-specific promoters (17, 30, 389, 606).”
BackgroundOsteoclast signalling pathways
Blair, H. C., Robinson, L. J., & Zaidi, M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.077 · Cited by 174
The Activity of Peptides of the Calcitonin Family in Bone
Naot, D., Musson, D. S., & Cornish, J. (2019) · Physiological Reviews · doi:10.1152/physrev.00066.2017 · Cited by 141
“The first CTR cDNA was cloned from porcine (134), followed by the cloning of the receptors from human and rat (7, 81, 127, 187).”
BackgroundFSH-receptor isoforms and FSH-dependent gene transcription in human monocytes and osteoclasts
Robinson, L. J., Tourkova, I., Wang, Y., Sharrow, A. C., Landau, M. S., Yaroslavskiy, B. B., Sun, L., Zaidi, M., & Blair, H. C. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.02.112 · Cited by 139
“Glycoprotein hormone receptors act including Gαs (cAMP/cAMP-dependent protein kinase) or Gαi/o pathways [8] both of which occur in osteoclasts [9,10].”
BackgroundLaburthe, M., Couvineau, A., Gaudin, P., Maoret, J.-J., Rouyer‐Fessard, C., & Nicole, P. (2006) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb17476.x · Cited by 148
Grammatopoulos, D. K., Dai, Y., Randeva, H., Levine, M. A., Karteris, E., Easton, A. J., & Hillhouse, E. W. (1999) · Molecular Endocrinology · doi:10.1210/me.13.12.2189 · Cited by 124
“The calcitonin receptor family is of particular interest since it appears to have a very similar isoform profile to the CRH-R1 receptor family; both receptors have splice variants that contain inserts in the first intracellular loop (16 and 29 amino acids in the calcitonin and CRH-R1 receptor, respectively) (7, 30) an…”
BackgroundMolecular Pharmacology of the Calcitonin Receptor
Purdue, B. W., Tilakaratne, N., & Sexton, P. M. (2002) · Receptors and Channels · doi:10.1080/10606820213681 · Cited by 113
Rothe, L., Collin-Osdoby, P., Chen, Y., Sunyer, T., Chaudhary, L., Tsay, A., Goldring, S., Avioli, L., & Osdoby, P. (1998) · Endocrinology · doi:10.1210/endo.139.10.6247 · Cited by 103
“Human bone tissue samples from giant cell tumors of bone or individuals with rheumatoid arthritis were fixed in 4% paraformaldehyde (PF) for 2 days, decalcified (#5 weeks) in 14% EDTA, washed in graded ethanols, transferred to xylenes, and embedded in paraffin, and thin sections (5 mm) were cut and dried onto poly-l-l…”
MethodSelf-citationCalcitonin treatment for central giant cell granulomas of the mandible: Report of two cases
Pogrel, M. A., Regezi, J. A., Harris, S. T., & Goldring, S. R. (1999) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/s0278-2391(99)90828-5 · Cited by 101
Self-citationTaboulet, J. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.13.2129 · Cited by 100
Matayoshi, A., Brown, C., DiPersio, J. F., Haug, J., Abu‐Amer, Y., Liapis, H., Kuestner, R. E., & Pacifici, R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10785 · Cited by 98
Masi, L., Becherini, L., Colli, E., Gennari, L., Mansani, R., Falchetti, A., Becorpi, A. M., Cepollaro, C., Gonnelli, S., Tanini, A., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8880 · Cited by 102
Albrandt, K., Brady, E. M., Moore, C. X., Mull, E., Sierzega, M. E., & Beaumont, K. (1995) · Endocrinology · doi:10.1210/endo.136.12.7588285 · Cited by 88
Genetic Determinants of Bone Mass
Audí, L., García‐Ramírez, M., & Carrascosa, A. (1999) · Hormone Research in Paediatrics · doi:10.1159/000023343 · Cited by 87
Shyu, J.-F., Inoue, D., Baron, R., & Horne, W. C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31127 · Cited by 78
Calcitonin and calcitonin receptors.
Masi, L., & Brandi, M. L. (2007) · PubMed · Cited by 105
Calcitonin and Bone Physiology: In Vitro, In Vivo, and Clinical Investigations
Xie, J., Guo, J., Kanwal, Z., Wu, M., Lv, X., Ibrahim, N. A., Li, P., Buabeid, M. A., Arafa, E. A., & Sun, Q. (2020) · International Journal of Endocrinology · doi:10.1155/2020/3236828 · Cited by 83
Hilton, J., Dowton, M., Houssami, S., & Sexton, P. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1660213 · Cited by 70
“In contrast, despite lower affinity and efficacy at the receptors, the chimeric analogue sCT(1–16)-hCT(17–32) displayed poorly reversible binding, similar to sCT. Analysis of the dissociation kinetics of sCT analogues with differing -helix forming potential indicated that the ability to form…”
BackgroundAnusaksathien, O., Laplace, C., Li, X., Ren, Y., Peng, L., Goldring, S. R., & Galson, D. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007104200 · Cited by 67
Self-citationBone Disease in Rheumatological Disorders
Goldring, S. R., & Polisson, R. P. (1998) · Elsevier eBooks · doi:10.1016/b978-012068700-8/50022-0 · Cited by 60
Self-citationMasi, L., Becherini, L., Gennari, L., Colli, E., Mansani, R., Falchetti, A., Cepollaro, C., Gonnelli, S., Tanini, A., & Brandi, M. L. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8445 · Cited by 57
Structural Determinants of Salmon Calcitonin Bioactivity
Andreotti, G., Mendez, B. L., Amodeo, P., Morelli, M. A. C., Nakamuta, H., & Motta, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603528200 · Cited by 56
Heterodimers and family-B GPCRs: RAMPs, CGRP and adrenomedullin
Conner, A. C., Simms, J., Hay, D. L., Mahmoud, K., Howitt, S. G., Wheatley, M., & Poyner, D. R. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320843 · Cited by 56
Berlot, C. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201330200 · Cited by 47
The genomic organization of the human corticotropin-releasing factor type-1 receptor
Sakai, K., Yamada, M., HORIBA, N., Wakui, M., Demura, H., & Suda, T. (1998) · Gene · doi:10.1016/s0378-1119(98)00322-9 · Cited by 43
Born, W., Fischer, J. A., & Muff, R. (2002) · Receptors and Channels · doi:10.1080/10606820213683 · Cited by 45
Pham, V., Wade, J. D., Purdue, B. W., & Sexton, P. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307214200 · Cited by 40
Central giant cell lesion of the jaw: Nonsurgical treatment with calcitonin nasal spray
Allon, D. M., Anavi, Y., & Calderon, S. (2009) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/j.tripleo.2009.02.013 · Cited by 38
Focus on the splicing of Secretin GPCRs transmembrane-domain 7
Markovic, D., & Grammatopoulos, D. K. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.06.002 · Cited by 39
G-protein coupled receptors in bone
Bowler, W. B. (1998) · Frontiers in bioscience · doi:10.2741/a320 · Cited by 33
“Although CR display some tissue specificity, osteoclasts express both the insert positive and negative isoforms, however, Northern analysis studies suggest that the insert negative receptor is the predominant isoform (25, 32, 50).”
BackgroundWookey, P. J., McLean, C., Hwang, P. Y. K., Furness, S. G. B., Nguyen, S., Kourakis, A., Hare, D. L., & Rosenfeld, J. V. (2012) · Histopathology · doi:10.1111/j.1365-2559.2011.04146.x · Cited by 31
Marie, J.-C., Wakkach, A., Coudray, A.-M., Chastre, E., Berrih‐Aknin, S., & Gespach, C. P. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.4.2103 · Cited by 31
Pham, V., Dong, M., Wade, J. D., Miller, L. J., Morton, C. J., Ng, H., Parker, M. W., & Sexton, P. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503272200 · Cited by 29
Self-citationRaggatt, L., Evdokiou, A., & Findlay, D. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1670093 · Cited by 29
“When expressed in a number of cell types the insert +ve receptor isoform displays similar affinity for CT as the insert ve variant (Nussenzveig et al. 1994, Albrandt et al. 1995, Gorn et al. 1995, Moore et al. 1995) but has markedly altered G-protein coupling efficiency ( Gorn et al. 1995, Moore et al. 1995).”
BackgroundIn vitro characterization of a human calcitonin receptor gene polymorphism
Wolfe, L. A., Fling, M. E., Xue, Z., Armour, S. L., Kerner, S. A., Way, J. M., Rimele, T., & Cox, R. F. (2003) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(02)00282-8 · Cited by 30
A novel promoter regulates calcitonin receptor gene expression in human osteoclasts
Shen, Z., Crotti, T. N., Flannery, M. R., Matsuzaki, K., Goldring, S. R., & McHugh, K. P. (2007) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/j.bbaexp.2007.08.005 · Cited by 30
Self-citationSerpentine receptors for parathyroid hormone, calcitonin and extracellular calcium ions
Brown, E. M., Segre, G. V., & Goldring, S. R. (1996) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(96)80346-6 · Cited by 27
Self-citationFish calcitonin receptor has novel features
Nag, K., Kato, A., Sultana, N., Ogoshi, M., Takei, Y., & Hirose, S. (2007) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2007.06.017 · Cited by 24
Multiple Domains Interacting with Gs in the Porcine Calcitonin Receptor
Orcel, P., Tajima, H., Murayama, Y., Fujita, T., Krane, S. M., Ogata, E., Goldring, S. R., & Nishimoto, I. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.1.0401 · Cited by 24
“Not only the expression level of transfected authentic CTR (number per cell) but also the calculated value of the transfected CTR capacity to produce maximal cAMP response (pmol/receptor) was comparable to those previously reported (27).”
ResultSelf-citationTsai, F., Chen, W., Chen, H., & Tsai, C. (2003) · Gynecologic and Obstetric Investigation · doi:10.1159/000070179 · Cited by 27
Tabrizi, R., Fardisi, S., Zamiri, B., Amanpour, S., & Karagah, T. (2016) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.ijom.2016.02.016 · Cited by 22
“Two distinct cDNAs encoding the CTRs on CGCGs have been reported.(19) It has been concluded that the first intracellular domain of the CTR is involved in ligand binding and signal transduction via the G protein/adenylate cyclase system.”
BackgroundTeli, T., Markovic, D., Hewitt, M. E., Levine, M. A., Hillhouse, E. W., & Grammatopoulos, D. K. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.08.014 · Cited by 21
Effects of Prostaglandins on Human Hematopoietic Osteoclast Precursors
Roux, S., Pichaud, F., Quinn, J. M. W., Lalande, A., Morieux, C., Jullienne, A., & de Vernejoul, M. C. (1997) · Endocrinology · doi:10.1210/en.138.4.1476 · Cited by 22
A novel calcitonin receptor gene in human osteoclasts from normal bone marrow
Nishikawa, T., Ishikawa, H., Yamamoto, S., & Koshihara, Y. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01176-x · Cited by 23
Blower, P. J., Puncher, M. R. B., Kettle, A. G., George, S. E., Dorsch, S., Leak, A. M., Naylor, L. H., & O'Doherty, M. J. (1998) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050200 · Cited by 20
Calcitonin receptor mRNA expression in TT cells: Effect of dexamethasone
Frendo, J., Delage-Mourroux, R., Cohen, R., Pichaud, F., Pidoux, E., Guliana, J. M., & Jullienne, A. (1998) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00075-6 · Cited by 22
Gilabert‐Oriol, R., Furness, S. G. B., Stringer, B. W., Weng, A., Fuchs, H., Day, B. W., Kourakis, A., Boyd, A., Hare, D. L., Thakur, M., et al. (2017) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-017-2013-z · Cited by 22
“Furthermore, CTR is also expressed in other malignancies including multiple myeloma [26], leukaemia [17], lymphoma [27], bone tumours [28, 29], breast [30] and prostate cancers [31, 32], and medullary thyroid cancers [33].”
BackgroundCalcitonin/PAC1 receptor splice variants: a blind spot in migraine research
Rees, T. A., Labastida‐Ramírez, A., & Rubio‐Beltrán, E. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2023.07.003 · Cited by 17
The final pathogenetic steps in focal bone erosions in rheumatoid arthritis
Goldring, S. R. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.suppl_1.i72 · Cited by 18
Self-citationUdawela, M., Christopoulos, G., Morfis, M. M., Tilakaratne, N., Christopoulos, A., & Sexton, P. M. (2007) · Regulatory Peptides · doi:10.1016/j.regpep.2007.08.003 · Cited by 18
Phosphorylation of the Human Calcitonin Receptor by Multiple Kinases Is Localized to the C-Terminus
Nygaard, S. C., Kuestner, R. E., Moore, E. E., & Stroop, S. D. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.10.1681 · Cited by 16
Identification of a novel calcitonin-response element in the promoter of the human p21WAF1/CIP1 gene
Evdokiou, A., Raggatt, L. J., Sakai, T., & Findlay, D. (2000) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0250195 · Cited by 18
“Unlike the insert-negative form, the insert-positive form does not signal via phospholipase C/Ca2+-mediated pathways, although it retains a cell type-dependent capacity to signal via coupling to adenylate cyclase (Nussenzveig et al. 1994, Gorn et al. 1995, Moore et al. 1995).”
BackgroundBeaudreuil, J., Taboulet, J., Orcel, P., Graulet, A. M., Denne, M. A., Baudoin, C., Jullienne, A., & de Vernejoul, M. C. (2000) · Bone · doi:10.1016/s8756-3282(00)00305-7 · Cited by 16
Paracrine Regulation of Thyroid-Hormone Synthesis by C Cells
Mara, J. F., Morillo-Bernal, J., Garca-Marn, R., Carmelo, J., & Martn-Lacave, I. (2012) · InTech eBooks · doi:10.5772/46178 · Cited by 15
“In humans, two isoforms (h-CTR1 and h-CTR2) differing by a 16 amino-acid insert in the first intracellular loop have been reported [78].”
Primary Giant Cell Tumor of Soft Tissue
Kim, N. R., & Han, J. (2003) · Acta Cytologica · doi:10.1159/000326657 · Cited by 12
Molecular characterization of two novel isoforms of the human calcitonin receptor
Beaudreuil, J., Balasubramanian, S., Chenais, J., Taboulet, J., Frenkian, M., Orcel, P., Jullienne, A., Horne, W. C., de Vernejoul, M. C., & Cressent, M. (2004) · Gene · doi:10.1016/j.gene.2004.08.019 · Cited by 16
Wookey, P. J., Zulli, A., Lo, C. Y., Hare, D. L., Schwarer, A. P., Darby, I. A., & Leung, A. Y. H. (2009) · Springer eBooks · doi:10.1007/978-90-481-2909-6_13 · Cited by 16
“CTR mRNA and splice variants have been sequenced from several species (Lin et al. 1991; Gorn et al. 1992; Albrandt et al. 1993; Kuestner et al. 1994; Yamin et al. 1994; Gorn et al. 1995; Nussenzveig et al. 1995).”
BackgroundBuilding the case for the calcitonin receptor as a viable target for the treatment of glioblastoma
Gupta, P., Furness, S. G. B., Bittencourt, L. F. F., Hare, D. L., & Wookey, P. J. (2020) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835920978110 · Cited by 10
Wookey, P. J. (2009) · The Open Zoology Journal · doi:10.2174/1874336600902010053 · Cited by 8
Calcitonin receptor expression in medullary thyroid carcinoma
Cappagli, V., Potes, C. S., Ferreira, L. B., Tavares, C., Eloy, C., Elisei, R., Sobrinho-Simões, M. A., Wookey, P. J., & Soares, P. (2017) · PeerJ · doi:10.7717/peerj.3778 · Cited by 9
“…& Robinson, 1989), breast (Findlay et al., 1981; Gillespie et al., 1997; Kuestner et al., 1994), brain (Wookey et al., 2012a), bone osteoclasts (Gorn et al., 1995; Nicholson et al., 1987), prostate (Thomas, Muralidharan & Shah, 2007), and of lymphoid (Marx et al., 1974) and myeloid tissues…”
BackgroundMiyamoto, K., Nishioka, T., Waki, Y., Nomura, M., Katsuta, H., Yokogawa, K., & Amano, H. (2006) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-006-0682-3 · Cited by 8
“It has been reported that CT immobilizes and contracts osteoclasts away from the bone surface through the action of cAMP enhanced because of stimulation of CT-R [ 25 ]; however, osteoclasts continuously exposed to CT can escape the effects of CT as a result of rapid profound reduction in CT-R mRNA expression [26].”
BackgroundNakamura, M., Yang, Q., Ozaki, T., Nakamura, Y., Yamasaki, H., Mori, I., & Kakudo, K. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6260 · Cited by 8
Rheumatoid Arthritis and other Inflammatory Joint Pathologies
Goldring, S. R., & Goldring, M. B. (2006) · Elsevier eBooks · doi:10.1016/b9-78-012088-5/62650-0522 · Cited by 8
Self-citationThe Structure and Molecular Biology of the Calcitonin Receptor
Goldring, S. R. (1998) · Advances in organ biology · doi:10.1016/s1569-2590(08)60113-5 · Cited by 8
Self-citationCalcitonin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
Hay, D. L., Poyner, D. R., & Walker, C. S. (2019) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f11/2019.4 · Cited by 6
Giant-Cell Tumors of Bone and Progesterone Receptors
Demertzis, N. S., Kotsiandri, F., Giotis, I., & Apostolikas, N. (2003) · Orthopedics · doi:10.3928/0147-7447-20031201-10 · Cited by 6
Structure and Molecular Biology of the Calcitonin Receptor
Galson, D. L., & Goldring, S. R. (2002) · Elsevier eBooks · doi:10.1016/b978-012098652-1.50136-0 · Cited by 9
Self-citationOsaki, T., Katafuchi, T., & Minamino, N. (2008) · The Journal of Biochemistry · doi:10.1093/jb/mvn084 · Cited by 6
Hillhouse, E. W., & Grammatopoulos, D. K. (2001) · Stress · doi:10.3109/10253890109014748 · Cited by 6
Martin, T. J., Findlay, D. M., Moseley, J. M., & Sexton, P. M. (1998) · Elsevier eBooks · doi:10.1016/b978-012068700-8/50005-0 · Cited by 7
Iodocalcitonin binds to human calcitonin receptors with higher affinity than calcitonin
Cohen, D., Nussenzveig, D. R., & Gershengorn, M. C. (1996) · Endocrinology · doi:10.1210/en.137.10.4507 · Cited by 7
Yamashita, T., Tose, K., & Shichida, Y. (2008) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2008.00327.x · Cited by 4
“amino acids) in the N-terminal portion of CL1 and showed diminished Gs coupling ability (34).”
BackgroundNaot, D., Musson, D. S., & Cornish, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00033-6 · Cited by 4
Jelaska (2000) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200010)43:10 · Cited by 2
Self-citationMolecular biology and regulation of the calcitonin receptor
Goldring, S. R. (1997) · Journal of Bone and Mineral Metabolism · doi:10.1007/bf02490074 · Cited by 2
“identified two additional CT receptor isoforms that were cloned from human giant cell tumor of bone [52].”
BackgroundSelf-citationLa calcitonine et son récepteur
Frendo, J., Moukhtar, M. S., & Orcel, P. (2000) · Revue du Rhumatisme · doi:10.1016/s1169-8330(00)80077-0 · Cited by 3
Amylin and Calcitonin Gene-Related Peptide
Naot, D., Reid, I. R., & Cornish, J. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00056-2 · Cited by 2
Basic Aspects of Calcitonin in Skeletal Health
Gennari, C. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-278-4_20 · Cited by 1
Reddy, S. V., & Roodman, G. D. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-736-9_14 · Cited by 1
Calcitonin receptors in GtoPdb v.2023.1
Garelja, M. L., Hay, D. L., Poyner, D. R., & Walker, C. S. (2023) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f11/2023.1 · Cited by 3
Calcitonin receptors in GtoPdb v.2021.2
Hay, D. L., Poyner, D. R., & Walker, C. S. (2021) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f11/2021.2 · Cited by 1
Loss of Calcitonin Binding in Rat Is Not Related to Calcitonin Receptor Gene Abnormality
Nakamura, M., Yang, Q., Gouda, T., Takehara, A., Ohta, H., Miyajima, M., & Kakudo, K. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5097 · Cited by 1
Pham, V., Wade, J. D., & Sexton, P. M. (2003) · International Journal of Peptide Research and Therapeutics · doi:10.1007/bf02442576
The influence of modified chitosan substrates on osteoclastogenesis
Torres, A. L. (2011) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/e4jq-ms17 · Cited by 1
C1‐Inhibitor to Choriogonadotropin
Haeberli, A. (1998) · Wiley eBooks · doi:10.1002/9783527619764.ch3
Abdelfattah, A. S. (2016) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.ijom.2016.07.009
“Moreover, unlike GCTs, CGCGs reveal neither high stromal cellularity nor necrosis.2 Cytogenetically, CGCGs do not demonstrate recurrent p.Gly34 Trp or p.Gly34 Leu mutations in the H3F3A gene.3 However, the H3F3A mutation is evident, almost specifically, in GCT.4 Based on this confusion between the two diseases, Tabriz…”
BackgroundInfluentialStephen M. Krane: A Scholar and a Gentleman
(2015) · Matrix Biology · doi:10.1016/j.matbio.2015.04.009
Morrison, N. A., Nicholson, G. C., Mason, R. S., & Quinn, R. (1997) · Emerging Therapeutic Targets · doi:10.1517/14728222.1.1.207
Wookey, P. J., Gupta, P., Hare, D. L., Ciccotosto, G. D., & Hutchings, C. J. (2022) · Springer eBooks · doi:10.1007/978-3-030-80962-1_261-1 · Cited by 2
Metadata
- Authors
- Gorn, A. H., Rudolph, S. M., Flannery, M. R., Morton, C. C., Weremowicz, S., Wang, T. Z., Krane, S. M., & Goldring, S. R.
- Affiliations
- Harvard University (US)
- Brigham and Women's Hospital (US)
- ORCID
- Morton, C C
- Venue
- Journal of Clinical Investigation
- Published
- 1995-06-01
- Volume
- 95
- Issue
- 6
- Pages
- 2680-2691
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC295951
- OpenAlex
- W2094192333
- Cited by
- 100
- References
- 66
- Citations by year
- 2025: 1 · 2023: 2 · 2022: 1 · 2021: 1 · 2020: 2 · 2019: 2 · 2018: 1 · 2017: 6 · 2016: 2 · 2015: 1 · 2013: 1 · 2012: 2
- FWCI
- 2.48
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- National Institutes of Health (5p01ar003564-38)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 46773, R01DK046773)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR 03564, AR-07258, T32AR007258)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Keywords
- calcitonin receptor, receptor isoforms, giant cell tumor of bone, ligand binding affinity, cAMP signaling, salmon calcitonin, human calcitonin, osteoclast-like cells
- MeSH terms
- Cyclic AMP, Animals, Base Sequence, Bone Neoplasms, Calcitonin, Cell Line, Chlorocebus aethiops, Chromosomes, Human, Pair 7, Cloning, Molecular, Genes, Giant Cell Tumors, Humans, Ligands, Molecular Sequence Data, RNA, Messenger, Structure-Activity Relationship, Transfection, Signal Transduction, Gene Expression, In Situ Hybridization, DNA Primers, Receptors, Calcitonin, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.